Stroke: international polypill ready to go
The global clinical trial of the PILL Pilot (aka polypill) is well on the way, now that almost 400 participants have been recruited from Australia, New Zealand, India, the UK, The Netherlands, and Brazil.
The trial, involving the George Institute, will evaluate the safety, tolerability and efficacy of the polypill compared with placebo in people at moderately increased risk of heart attack or stroke. It will study the short-term effects of the pill on blood pressure and cholesterol and how well it is tolerated among the participants.
The George Institute in Australia recruited 21 participants in this country.
The polypill is a low-cost, fixed-dose medication that combines two blood pressure-lowering drugs, a statin and aspirin, in the one capsule.
Results are anticipated in March or April.
Published: 15 Feb 2010